Joseph Limber

Plus aucun poste en cours

Profil

Joseph M.
Limber is currently Chief Executive Officer at Garda Therapeutics, Inc. Formerly, Mr. Limber was President & Chief Executive Officer at Monogram Biosciences, Inc. from 1998 to 2002; President & Chief Executive Officer at Deltagen, Inc. in 2003; President, Chief Executive Officer & Director at Genoptix, Inc. from 2017 to 2018; President & Chief Executive Officer at Gradalis, Inc. from 2013 to 2015; President, Chief Executive Officer & Director at Prometheus Laboratories, Inc. from 2004 to 2013; President, Chief Executive Officer & Director at Secura Bio, Inc.; Chairman at Molecular Insight Pharmaceuticals, Inc. in 2010; Executive Chairman at ImaginAb, Inc. from 2016 to 2017; Director at V.I.
Technologies, Inc.; Independent Non-Executive Director at CombiMatrix Corp.
in 2012; Director at Panacos Pharmaceuticals, Inc. from 2001 to 2009; Independent Director at XOMA Royalty Corp.
from 2012 to 2026; Executive Vice President at SEQUUS Pharmaceuticals, Inc.; and President & Chief Operating Officer at Praecis Pharmaceuticals, Inc. from 1996 to 1998.
Education includes undergraduate studies at Duquesne University of The Holy Spirit.

Anciens postes connus de Joseph Limber

Sociétés	Poste	Fin
XOMA ROYALTY CORPORATION	Directeur/Membre du Conseil	14/07/2026
Genoptix, Inc.	Directeur Général	01/12/2018
ImaginAb, Inc.	Président	01/11/2017
Gradalis, Inc.	Directeur Général	01/04/2015
Prometheus Laboratories, Inc.	Directeur Général	01/04/2013